JPS63174926A - Anticoccidial agent for domestic fowl - Google Patents
Anticoccidial agent for domestic fowlInfo
- Publication number
- JPS63174926A JPS63174926A JP392087A JP392087A JPS63174926A JP S63174926 A JPS63174926 A JP S63174926A JP 392087 A JP392087 A JP 392087A JP 392087 A JP392087 A JP 392087A JP S63174926 A JPS63174926 A JP S63174926A
- Authority
- JP
- Japan
- Prior art keywords
- bismuth
- mol
- compound
- tri
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940124536 anticoccidial agent Drugs 0.000 title claims abstract description 11
- 239000003224 coccidiostatic agent Substances 0.000 title claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 34
- -1 N,N-dimethylaminothiocarbonylthio Chemical group 0.000 claims abstract description 26
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 13
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 8
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
- 244000144977 poultry Species 0.000 claims description 19
- 239000000460 chlorine Substances 0.000 claims description 11
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 9
- 239000011737 fluorine Substances 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical group [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 2
- 150000001540 azides Chemical class 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910002651 NO3 Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 11
- 150000001622 bismuth compounds Chemical class 0.000 abstract description 7
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 230000001165 anti-coccidial effect Effects 0.000 abstract description 4
- 231100000053 low toxicity Toxicity 0.000 abstract description 3
- KWEDUNSJJZVRKR-UHFFFAOYSA-N carbononitridic azide Chemical compound [N-]=[N+]=NC#N KWEDUNSJJZVRKR-UHFFFAOYSA-N 0.000 abstract description 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract description 2
- 241000272496 Galliformes Species 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 54
- 229910052797 bismuth Inorganic materials 0.000 description 35
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 31
- 238000006243 chemical reaction Methods 0.000 description 26
- 239000007787 solid Substances 0.000 description 26
- 238000004519 manufacturing process Methods 0.000 description 25
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 24
- 238000002844 melting Methods 0.000 description 20
- 230000008018 melting Effects 0.000 description 20
- 239000000203 mixture Substances 0.000 description 17
- 235000013594 poultry meat Nutrition 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 239000002904 solvent Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 208000003495 Coccidiosis Diseases 0.000 description 9
- 206010023076 Isosporiasis Diseases 0.000 description 9
- TXKAQZRUJUNDHI-UHFFFAOYSA-K bismuth tribromide Chemical compound Br[Bi](Br)Br TXKAQZRUJUNDHI-UHFFFAOYSA-K 0.000 description 9
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 8
- 238000004817 gas chromatography Methods 0.000 description 7
- 208000035861 hematochezia Diseases 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 208000027503 bloody stool Diseases 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000029142 excretion Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- QWMMHFXTVYRMTO-UHFFFAOYSA-L dichloro(triphenyl)bismuthorane Chemical compound C=1C=CC=CC=1[Bi](Cl)(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 QWMMHFXTVYRMTO-UHFFFAOYSA-L 0.000 description 4
- LTYMSROWYAPPGB-UHFFFAOYSA-N diphenyl sulfide Chemical compound C=1C=CC=CC=1SC1=CC=CC=C1 LTYMSROWYAPPGB-UHFFFAOYSA-N 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 4
- ZHXAZZQXWJJBHA-UHFFFAOYSA-N triphenylbismuthane Chemical compound C1=CC=CC=C1[Bi](C=1C=CC=CC=1)C1=CC=CC=C1 ZHXAZZQXWJJBHA-UHFFFAOYSA-N 0.000 description 4
- AANIAVJNQBPGAD-UHFFFAOYSA-N tris(3-fluorophenyl)bismuthane Chemical compound FC1=CC=CC([Bi](C=2C=C(F)C=CC=2)C=2C=C(F)C=CC=2)=C1 AANIAVJNQBPGAD-UHFFFAOYSA-N 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- JHXKRIRFYBPWGE-UHFFFAOYSA-K bismuth chloride Chemical compound Cl[Bi](Cl)Cl JHXKRIRFYBPWGE-UHFFFAOYSA-K 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- POXFSUSZHLHQPG-UHFFFAOYSA-N nitric acid;triphenylbismuthane Chemical compound O[N+]([O-])=O.O[N+]([O-])=O.C1=CC=CC=C1[Bi](C=1C=CC=CC=1)C1=CC=CC=C1 POXFSUSZHLHQPG-UHFFFAOYSA-N 0.000 description 3
- YPJKMVATUPSWOH-UHFFFAOYSA-N nitrooxidanyl Chemical group [O][N+]([O-])=O YPJKMVATUPSWOH-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- USSLSRWKBNOKJN-UHFFFAOYSA-N tris(4-chlorophenyl)bismuthane Chemical compound C1=CC(Cl)=CC=C1[Bi](C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 USSLSRWKBNOKJN-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- 241000224483 Coccidia Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000223924 Eimeria Species 0.000 description 2
- 241000499563 Eimeria necatrix Species 0.000 description 2
- 241000223932 Eimeria tenella Species 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- ZFKNATGBRIBXIG-UHFFFAOYSA-M bis(4-chlorophenyl)-iodobismuthane Chemical compound C1=CC(Cl)=CC=C1[Bi](I)C1=CC=C(Cl)C=C1 ZFKNATGBRIBXIG-UHFFFAOYSA-M 0.000 description 2
- RWMLVMBSSADKRA-UHFFFAOYSA-L bismuth(2+);diacetate Chemical compound [Bi+2].CC([O-])=O.CC([O-])=O RWMLVMBSSADKRA-UHFFFAOYSA-L 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002133 anti-thiamin Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- JVTDFPZHWDDPPR-UHFFFAOYSA-N azido(diphenyl)bismuthane Chemical compound C=1C=CC=CC=1[Bi](N=[N+]=[N-])C1=CC=CC=C1 JVTDFPZHWDDPPR-UHFFFAOYSA-N 0.000 description 1
- 229940054066 benzamide antipsychotics Drugs 0.000 description 1
- 150000003936 benzamides Chemical class 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125936 compound 42 Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- AXAIHGXEQFPLFL-UHFFFAOYSA-L dichlorobismuth Chemical compound Cl[Bi]Cl AXAIHGXEQFPLFL-UHFFFAOYSA-L 0.000 description 1
- QEGVWZKOYAPNPM-UHFFFAOYSA-N dicyanobismuthanylformonitrile Chemical compound N#C[Bi](C#N)C#N QEGVWZKOYAPNPM-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000002554 disease preventive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000012990 dithiocarbamate Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000003250 oocyst Anatomy 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229940127224 quinoline drug Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000036435 stunted growth Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- KOECRLKKXSXCPB-UHFFFAOYSA-K triiodobismuthane Chemical compound I[Bi](I)I KOECRLKKXSXCPB-UHFFFAOYSA-K 0.000 description 1
- AHOZOHRYBFURRF-UHFFFAOYSA-N tris(4-fluorophenyl)bismuthane Chemical compound C1=CC(F)=CC=C1[Bi](C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 AHOZOHRYBFURRF-UHFFFAOYSA-N 0.000 description 1
- ZOQXFEWZVKMARY-UHFFFAOYSA-N tris[3-(trifluoromethyl)phenyl]bismuthane Chemical compound FC(F)(F)C1=CC=CC([Bi](C=2C=C(C=CC=2)C(F)(F)F)C=2C=C(C=CC=2)C(F)(F)F)=C1 ZOQXFEWZVKMARY-UHFFFAOYSA-N 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
発明の背景
本発明は、有機ビスマス化合物を有効成分とする家禽用
抗コクシジウム剤に関するものである。DETAILED DESCRIPTION OF THE INVENTION Background of the Invention The present invention relates to an anticoccidial agent for poultry containing an organic bismuth compound as an active ingredient.
従来技術とその問題点
コクシジウム症は、コクシジウム属の微生物による感染
症である。主として、アイメリア・テネラ(Eimer
ia tenella)およびアイメリア・ネカトリッ
クス(E、necatrix)に感染した家禽類に発現
し、消化管出血、斃死あるいは成長抑制等の様々な症状
を示す。家禽類には、例えば鶏、七面鳥およびアヒル等
が含まれるが、これらが営業上の目的で飼育されている
養鶏場におけるコクシジウム症の集団発生は、経営者に
極めて大きな損失をもたらすので、しばしば深刻な問題
となっている。Prior art and its problems Coccidiosis is an infectious disease caused by microorganisms of the genus Coccidia. Mainly Eimeria tenera (Eimer
It occurs in poultry infected with E. necatrix and E. necatrix, and exhibits various symptoms such as gastrointestinal bleeding, mortality, and stunted growth. Outbreaks of coccidiosis at poultry farms where poultry, including chickens, turkeys, and ducks, are raised for commercial purposes are often serious concerns, as they result in extremely large losses for the operators. This has become a serious problem.
従って、コクシジウム症の予防および治療に有効な抗コ
クシジウム剤に大きな関心が寄せられている。Therefore, there is great interest in anti-coccidial agents that are effective in preventing and treating coccidiosis.
従来、抗コクシジウム剤としてはサルファ剤、ニトロフ
ラン剤、キノリン剤、抗チアミン剤およびベンゾアミド
類などが実用に供され現在は主として抗生物質が使用さ
れている。これらは主作用である抗コクシジウム作用の
強度が左程強くない上、宿主に対する毒性に問題がある
。また、薬剤の永年使用によって薬剤耐性株が出現し、
そのために薬剤の効力が漸時低下するという事態が生起
している。このような事情を考慮し、耐性株に有効であ
ると同時に耐性を与え難い新規な型の家禽用抗コクシジ
ウム剤の開発が要望されている。Conventionally, sulfa drugs, nitrofuran drugs, quinoline drugs, antithiamine drugs, benzamides, and the like have been put into practical use as anticoccidial drugs, and currently antibiotics are mainly used. The strength of the main anti-coccidial effect of these drugs is not as strong as that shown in the left, and there are problems with toxicity to the host. Additionally, due to the long-term use of drugs, drug-resistant strains have emerged.
This has resulted in a situation where the efficacy of the drug gradually decreases. In consideration of these circumstances, there is a need for the development of a new type of anti-coccidial agent for poultry that is effective against resistant strains and at the same time does not easily impart resistance.
問題点を解決するための
本発明者らは上記の実情に鑑み、家禽類のコクシジウム
症を、有効に予防および治療し得ると共に、宿主である
家禽類にとって安全な抗コクシジウム剤を開発すること
を目的として研究を重ねた結果、既存の有機ビスマス化
合物の内、ある種のものが従来知られていなかった、優
れた抗コクシジウム作用を有することを見出し、本発明
を完成するに至った。In order to solve the problems, the present inventors have taken the above-mentioned circumstances into account and have set out to develop an anticoccidial agent that can effectively prevent and treat coccidiosis in poultry and is safe for the host poultry. As a result of repeated research aimed at this purpose, it was discovered that certain types of existing organic bismuth compounds have previously unknown, excellent anti-coccidiosis effects, leading to the completion of the present invention.
即ち、本発明は、一般式(■):
[式中、Aは水素、弗素、塩素、メチル、メトキシまた
はトリフルオロメチル、Sは1〜3の整数、Lは0〜2
の整数であって、Sが1のときtは!または2であり、
Lが1のときQは−I3r、(ピリジン)!または−B
rt(ジピリジル)、Lが2のときQはフェニルチオ
、N、N−ジメチルアミノチオカルボニルチオを表わし
、Sが2のときtはlであって、Qは沃素、シアノ、ア
ジド、−Br(フエ(テトラメチルアンモニウム・ハラ
イド)、または−I3r(テトラエチルアンモニウム・
ハライド)を表わし、Sが3のときLは011または2
であって、Lが1のときQ !t −0ff(OH)、
t7><2のときQは弗素、塩素、アセトキシまたは硝
酸根を表わすコ
で示される有機ビスマス化合物を有効成分とする家禽用
抗コクシジウム剤を提供するものである。That is, the present invention relates to the general formula (■): [wherein A is hydrogen, fluorine, chlorine, methyl, methoxy or trifluoromethyl, S is an integer of 1 to 3, and L is 0 to 2]
is an integer, and when S is 1, t is! or 2,
When L is 1, Q is -I3r, (pyridine)! or -B
rt (dipyridyl), when L is 2, Q represents phenylthio, N,N-dimethylaminothiocarbonylthio, when S is 2, t is l, and Q represents iodine, cyano, azide, -Br (phenylated). (tetramethylammonium halide), or -I3r (tetraethylammonium halide),
halide), and when S is 3, L is 011 or 2
And when L is 1, Q! t-0ff(OH),
When t7><2, Q represents a fluorine, chlorine, acetoxy or nitrate radical, and the present invention provides an anticoccidial agent for poultry containing an organic bismuth compound as an active ingredient.
上記の一般式(I)で示される化合物群は、さらに以下
の各群に分類され得る。即ち、それらは、一般式(II
)〜(■):
(R)mBi(Y)3−II、(IV)、 RBiBr
t・(L)n (V)。The compound group represented by the above general formula (I) can be further classified into the following groups. That is, they have the general formula (II
) ~ (■): (R)mBi(Y)3-II, (IV), RBiBr
t・(L)n(V).
(R)t[3iI3r−M (Vl)[式中、Rは弗
素、塩素、メチル、メトキシまたはトリフルオロメチル
で置換されていることもあるフェニル基、Xは弗素、塩
素、アセトキシまたは硝酸根、mは1〜3の整数であっ
て、mh<1のときYはフェニルチオまたはN、N−ジ
メチルアミノチオカルボニルチオ、mが2のときYは沃
素、シアノまたはアジド、nは1または2であって、n
が1のときしはジピリジル、nが2のときLはピリジン
、Mはフェニルトリメチルアンモニウム・ハライド、テ
トラメチルアンモニウム・ハライドまたはテトラエチル
アンモニウム・ハライドを表わすコ
で示される。(R)t[3iI3r-M (Vl) [wherein R is a phenyl group optionally substituted with fluorine, chlorine, methyl, methoxy or trifluoromethyl; X is a fluorine, chlorine, acetoxy or nitrate radical; m is an integer from 1 to 3; when mh<1, Y is phenylthio or N,N-dimethylaminothiocarbonylthio; when m is 2, Y is iodine, cyano or azide; n is 1 or 2; Te, n
When is 1, L is pyridine; when n is 2, L is pyridine; M is phenyltrimethylammonium halide, tetramethylammonium halide or tetraethylammonium halide;
上記の有機ビスマス化合物はいずれも既知化合物であり
、当業者に知られた方法に従って製造することができる
[フリートマン(I7 、 D 、 F reedma
n)およびボーク(C;、O,Poak)、ケミカル・
レビュース(Chemical Reviews) l
982.82.15〜57、ギルマン()I、 Q
ilman)およびエール(I(。All of the above organic bismuth compounds are known compounds and can be produced according to methods known to those skilled in the art [Friedman (I7, D, Freedma
n) and Poak (C;, O, Poak), chemical
Reviews (Chemical Reviews) l
982.82.15-57, Gilman () I, Q
ilman) and Yale (I(.
Yale)ケミカル・レビュース、1942.30.2
81〜320参照]。Yale) Chemical Reviews, 1942.30.2
81-320].
式(1)の全ての化合物はSが3でtが0の場合、即ち
、式C’N)のmが3の場合のRs B iから誘導す
ることができる。Ra13iの化合物は反応式(1)、
(2)に従って、ハロゲン化ビスマスとグリニヤール試
薬又はリヂウム試薬とをエーテル系溶媒内、熱時もしく
は冷時に反応させることにより製造できる。All compounds of formula (1) can be derived from Rs B i when S is 3 and t is 0, ie m is 3 in formula C'N). The compound of Ra13i has the reaction formula (1),
According to (2), it can be produced by reacting a bismuth halide with a Grignard reagent or a lithium reagent in an ether solvent, hot or cold.
(1)BiX’s+3nMgX’=RsBi千3MgX
’*(2)BiX’s+3RLi −4RsBi+3
LiX’(式中、XoはCI2又はBrを表わし、Rは
前記と同QFAである。)
式(n)及び(III)の化合物は反応式(3)に従っ
てfl、Biとハロゲンをクロロホルム、又は四塩化炭
素又は炭化水素系溶媒中10℃以下にて反応さ仕て11
3BiCf2を又はrtsI3i13rtを製造し、次
に反応式(4)に従って種々のナトリウム又はカリウム
塩、あるいは銀塩とアルコール又はアセトン中で熱時又
は室温で反応させると、式(■)の化合物が製造でき、
他方、反応式(5)に従ってアンモニア水と芳香族炭化
水素系溶媒中、室温で反応させると式(III)の化合
物が製造できる。(1) BiX's+3nMgX'=RsBi1,0003MgX
'*(2) BiX's+3RLi -4RsBi+3
LiX' (wherein, Xo represents CI2 or Br, and R is the same QFA as above.) Compounds of formulas (n) and (III) are prepared by reacting fl, Bi and halogen with chloroform, or Reaction in carbon tetrachloride or hydrocarbon solvent at 10°C or lower 11
When 3BiCf2 or rtsI3i13rt is produced and then reacted with various sodium or potassium salts or silver salts in alcohol or acetone at room temperature or hot according to reaction formula (4), the compound of formula (■) can be produced. ,
On the other hand, the compound of formula (III) can be produced by reacting with ammonia water in an aromatic hydrocarbon solvent at room temperature according to reaction formula (5).
(3)RaB i+ X’ t → Ra B I
X ’ t(4)R3B iX’ t+ X M’ →
I’t 3B iX 1+ ?、 M’ X’(5)R
iB iX’ t + N H40H→(式中、Xoは
CQまたはBr5XはFl−OCOCII3または硝酸
根、MoはNa、KまたはAgを表わす。)
式(IV)においてm力(2の化合物は反応式(6)に
従って、rLsB iと三臭化ビスマスとを2:1モル
比の割合でエーテル系溶媒中(好ましくはTHF中)に
て熱時再分配反応することにより、まず、R,l3i1
3rを製造し、次に反応式(7)に従って、種々のナト
リウム、又はカリウム塩と含水又は非水アルコール又は
含水又は非水アセトン中、室温にて反応する事によって
製造できる。(3) RaB i+ X' t → Ra B I
X' t(4)R3B iX' t+ X M' →
I't 3B iX 1+? , M'X'(5)R
iB iX' t + N H40H → (In the formula, Xo represents CQ or Br5X represents Fl-OCOCII3 or a nitrate group, and Mo represents Na, K or Ag.) In formula (IV), m force (the compound of 2 is a reaction formula According to (6), R, l3i1
3r, and then react with various sodium or potassium salts in a hydrous or non-aqueous alcohol or a hydrous or non-aqueous acetone at room temperature according to reaction formula (7).
(6)2RsBi+B1Br3→3RtB+Br(7)
11tI3inr+YM” →RtBiY+M’Br(
式中、RおよびYは前記の定義に従い、M”はNaまた
はKを表わず。)
式(IV)においてmが1の化合物は、反応式(8)に
従ってns[3iと三臭化ビスマスとを1:2モル比の
割合でエーテル系溶媒中(好ましくはエーテル)室温で
再分配反応を行ってRB iB rtを製造し、次に反
応式(9)もしくは(10)に従ってアセトン又はアル
コール等の溶媒中、室温でジアルキルジチオカーパーメ
ートのナトリウム塩又はカリウム塩と、あるいは塩基を
I−I B rのキャッチ剤としてメルカプタンと反応
させることにより製造することができる。(6) 2RsBi+B1Br3→3RtB+Br(7)
11tI3inr+YM"→RtBiY+M'Br(
(wherein R and Y are according to the above definitions, and M'' does not represent Na or K.) In the formula (IV), the compound where m is 1 is formed by combining ns[3i and bismuth tribromide] according to the reaction formula (8). to produce RB iB rt in a 1:2 molar ratio in an ether solvent (preferably ether) at room temperature, and then acetone or alcohol etc. according to reaction formula (9) or (10). It can be prepared by reacting with a sodium or potassium salt of a dialkyldithiocarpermate at room temperature in a solvent of 1-IBr, or with a mercaptan using a base as a catch agent for I-IBr.
(8)RsBi+213iBrs→3RBfBrt(9
)nBiBrt+M”ss CN(F)、−。(8) RsBi+213iBrs→3RBfBrt(9
) nBiBrt+M”ss CN(F), -.
RB i(S S CN (R’ )z)*+ 2 M
oB「(式中、R,M”は前記と同意義であり、R′は
メ+(塩基)(HBr)
(Rは前記と同Q義である。)
式(V)の化合物は反応式(11)または(12)に従
って芳香族炭化水素系溶媒又は炭化水素系溶媒中、室温
にて反応し製造することができる。RB i(S S CN (R')z) *+ 2 M
oB "(In the formula, R, M" have the same meanings as above, R' is Me + (base) (HBr) (R has the same Q definition as above.) The compound of formula (V) has the reaction formula It can be produced by reacting at room temperature in an aromatic hydrocarbon solvent or a hydrocarbon solvent according to (11) or (12).
(11)flI3 iBr、+nL−+IIB 1Br
t ・(L)n(12)2 rttI3iBr+ 2
L’ →nBiBrt・(L’)t+ RzB i
(式中、れは1または2、しはピリジンまたはジピリジ
ル、Loはピリジンを表わす)
式(VI)の化合物は反応式(13)に従ってアルコー
ル系溶媒又はアセトン中で、RtBiBrと第四級アン
モニウム塩とを熱時反応して製造することができる。(11) flI3 iBr, +nL-+IIB 1Br
t ・(L)n(12)2 rttI3iBr+ 2
L'→nBiBrt・(L')t+ RzB i (In the formula, "represents 1 or 2," represents pyridine or dipyridyl, and "Lo" represents pyridine.) The compound of formula (VI) is converted into an alcoholic solvent according to reaction formula (13). Alternatively, it can be produced by thermally reacting RtBiBr and a quaternary ammonium salt in acetone.
(13)RtBiI3r+M −’ [RtBIBr]
[M](式中、RおよびMは前記と同意義である。)以
上の製造化合物は全て再結晶又は沈降法によって、精製
することができる。又、化合物の同定は赤外、プロトン
核磁気共鳴、ハロゲン含↑、融点およびビスマス含量を
測定する事によって行った。(13) RtBiI3r+M −' [RtBIBr]
[M] (In the formula, R and M have the same meanings as above.) All of the above manufactured compounds can be purified by recrystallization or precipitation method. In addition, the compound was identified by measuring infrared rays, proton nuclear magnetic resonance, halogen content, melting point, and bismuth content.
上記の如くにして製造された一般式(1)で示される有
機ビスマス化合物は後述する如く、家禽のコクシジウム
症の予防および治療に有効である。The organic bismuth compound represented by the general formula (1) produced as described above is effective in preventing and treating coccidiosis in poultry, as described below.
また、宿主である家禽に対する毒性が低く、しかも、耐
性株を容易に出現しないので、極めて有用な抗コクシジ
ウム剤の主成分であると言える。In addition, it has low toxicity to the host poultry, and resistant strains do not easily appear, so it can be said to be the main component of an extremely useful anticoccidial agent.
一般式(1)の化合物を有効成分として含有する本発明
の家禽用コクシジウム予防治療剤は、単味または通常こ
の種の薬剤に使用される適当な担体と共に、場合により
賦形剤、崩壊剤、滑沢剤、コーティング剤などを用いて
、散剤、粒剤、溶液、懸濁液、プレミックス、カプセル
、乳剤、錠剤などの剤形に調製して使用することができ
る。The coccidia preventive and therapeutic agent for poultry of the present invention containing the compound of general formula (1) as an active ingredient may be used alone or together with a suitable carrier normally used for this type of drug, optionally an excipient, a disintegrant, It can be prepared and used in dosage forms such as powders, granules, solutions, suspensions, premixes, capsules, emulsions, and tablets using lubricants, coating agents, and the like.
投与に際しては、一般に家禽飼料中に本発明化合物を少
なくとも0.0℃重量%の割合で配合して与えればよい
が、予防治療薬として使用するには約0.O1〜約0.
08重量%、好ましくは約0゜02〜0.05重量%配
合すればよく、溶液、懸濁液、乳剤などは飲料水に添加
して使用11、カプセル剤、錠剤などはそのまま経口投
与すればよい。When administering, the compound of the present invention may generally be mixed into poultry feed at a ratio of at least 0.0°C by weight; O1 to about 0.
08% by weight, preferably about 0.02~0.05% by weight. Solutions, suspensions, emulsions, etc. can be added to drinking water11, and capsules, tablets, etc. can be administered orally as they are. good.
ここで担体は通常家禽の飼料または飲料水に添加できる
ものであればとくに制限されないが、水、乳糖、蔗糖、
タルク、コロイド状シリカ、ペクチン、小麦粉、米ぬか
、トウモロコシ粉、大豆、油粕、ひきわり穀粉、その他
市販の家禽用飼料などが例示される。Here, the carrier is not particularly limited as long as it can be added to poultry feed or drinking water, but water, lactose, sucrose,
Examples include talc, colloidal silica, pectin, wheat flour, rice bran, corn flour, soybean, oil cake, ground flour, and other commercially available poultry feeds.
なお、既知家禽用コクシジウム剤、寄生虫駆除剤、感染
症予防剤または生長促進剤を含む動物用医薬品と併用す
ることもできる。In addition, it can also be used in combination with veterinary drugs containing known poultry coccidial agents, antiparasitic agents, infectious disease preventive agents, or growth promoters.
以下に製造例を挙げ、本発明製剤の有効成分である一般
式(1)の化合物の製造方法を詳しく説明する。The method for producing the compound of general formula (1), which is the active ingredient of the preparation of the present invention, will be explained in detail below with reference to production examples.
製造例1 トリ(メタトリフルオロメチルフェニル)ビ
スマス(化合物12)
冷却管、温度計、撹拌機1滴下ロートの付いたlf2四
つロフラスコにMg13.3g(0,54モル)を入れ
窒素置換し加熱した。Production Example 1 Tri(metatrifluoromethylphenyl)bismuth (Compound 12) 13.3 g (0.54 mol) of Mg was placed in a LF2 four-bottle flask equipped with a cooling tube, a thermometer, and a stirring funnel, and the mixture was replaced with nitrogen and heated. did.
滴下ロートにメタトリフルオロメチルフェニルブロマイ
ド121.5g(0,54モル)とテトラヒドロフラン
230gの混合液を入れ、この5好を反応フラスコ中に
滴下した。反応の開始を確認した後、残液を50〜60
℃の温度で約2時間かけて滴下した。滴下後間温度で3
時間加熱して冷却した。別の滴下ロートに三塩化ビスマ
ス49.69(0,16モル)とテトラヒドロフラン2
00gの混合溶液を入れ、30℃以下の温度で滴下した
。還流を2時間行ない反応を終了した。冷却して30℃
以下の温度で飽和塩化アン宅ニウム水溶液200zQを
加えて水解した。A mixture of 121.5 g (0.54 mol) of metatrifluoromethylphenyl bromide and 230 g of tetrahydrofuran was placed in the dropping funnel, and the mixture was dropped into the reaction flask. After confirming the start of the reaction, reduce the remaining liquid to 50-60%
The mixture was added dropwise over a period of about 2 hours at a temperature of .degree. 3 at temperature after dropping
Heat for an hour and cool. In another dropping funnel, add 49.69 (0.16 mol) of bismuth trichloride and 2.2 mol of tetrahydrofuran.
00g of the mixed solution was added dropwise at a temperature of 30°C or lower. The reaction was completed by refluxing for 2 hours. Cool to 30℃
Hydrolysis was carried out by adding 200zQ of a saturated ammonium chloride aqueous solution at the following temperature.
何機層をデカントして取り出して濾過、濃縮すると84
.9gの固体を得た。これを減圧蒸留し、bp、 17
0〜!75℃/2mmHgの範囲で、無色固体のトリ(
メタトリフルオロメチルフェニル)ビスマス51gを得
た。融点35〜36℃、ガスクロマトグラフィー純度9
8.7%、Bi含ff132.1%(理論値32.4%
)。If you decant the layer, take it out, filter it, and concentrate it, it will be 84.
.. 9g of solid was obtained. This was distilled under reduced pressure, bp, 17
0~! Colorless solid tri(
51 g of bismuth (metatrifluoromethylphenyl) was obtained. Melting point 35-36℃, gas chromatography purity 9
8.7%, Bi content 132.1% (theoretical value 32.4%
).
製造例2 トリ(メタクロルフェニル)ビスマスジクロ
ライド(化合物26)
rθ
1)トリ(メタクロルフェニル)ビスマス(化合物メタ
トリフルオロメチルフェニルブロマイドの代りにメタク
ロルフェニルブロマイド103.4g(0,54モル)
を使用して製造例1と同様に反応し、生成物を石油エー
テルで再結晶することにより、融点53〜57℃の無色
の固体トリ(メタクロルフェニル)ビスマス43.59
を得た。Bi含量37.9%(理論値38.4%)、ガ
スクロマトグラフィー純度99.9%。Production Example 2 Tri(methachlorophenyl)bismuth dichloride (compound 26) rθ 1) Tri(methachlorophenyl)bismuth (103.4 g (0.54 mol) of methachlorophenyl bromide instead of the compound metatrifluoromethylphenyl bromide)
By reacting in the same manner as in Production Example 1 using
I got it. Bi content 37.9% (theoretical value 38.4%), gas chromatography purity 99.9%.
2)トリ(メタクロルフェニル)ビスマスジクロライド
このトリ(メタクロルフェニル)ビスマス209C0,
037モル)をクロロホルム100酎に溶解し反応フラ
スコに入れた。塩素39(0,042モル)を含むクロ
ロホルム液100m12を0℃で滴下した。2) Tri(methachlorophenyl) bismuth dichloride This tri(methachlorophenyl) bismuth 209C0,
037 mol) was dissolved in 100 ml of chloroform and placed in a reaction flask. 100 ml of a chloroform solution containing 39 (0,042 mol) of chlorine was added dropwise at 0°C.
濾過して濾液中のクロロホルムを威圧下一部濃縮して追
い出しメタノールを加えると結晶が析出した。これを減
圧濾過してとり出し、乾燥すると無色の固体のトリ(メ
タクロルフェニル)ビスマスジクロライド13.39を
得た。融点83〜85℃、塩素含ff1l 1;6%(
理論値11.5%)、ビスマス含fTh34 、1 %
(理論値3/i、0%)。After filtration, the chloroform in the filtrate was partially concentrated under pressure to drive it out, and methanol was added to precipitate crystals. This was taken out by filtration under reduced pressure and dried to obtain 13.39 of tri(methachlorophenyl)bismuth dichloride as a colorless solid. Melting point 83-85℃, chlorine content ff1l 1;6% (
Theoretical value 11.5%), bismuth content fTh34, 1%
(Theoretical value 3/i, 0%).
製造例3 トリ(メタクロルフェニル)ビスマスジフル
オライド(化合物35)
ρθ
反応フラスコに製造例2で得たトリ(メタクロルフェニ
ル)ビスマスジクロリド5g(0,008モル)、フッ
化カリウム3.89(0,032モル)、アセトン50
村を入れて、室温で2日間反応した。Production Example 3 Tri(methachlorophenyl)bismuth difluoride (compound 35) ρθ 5 g (0,008 mol) of tri(methachlorophenyl)bismuth dichloride obtained in Production Example 2 and 3.89 mol of potassium fluoride were placed in a reaction flask. 0,032 mol), acetone 50
The mixture was incubated for 2 days at room temperature.
威圧下、溶媒を一部濃縮して追い出し水を加えると微か
っ色の固体が析出した。減圧濾過して固体をとり出し、
水洗後、乾燥してアセトンで再結晶すると、融点194
〜197℃の無色固体のトリ(メタクロルフェニル)ビ
スマスジフルオライド2゜19を得た。ビスマス含ff
136.4%(理論値35゜9%)。When the solvent was partially concentrated under pressure and water was added, a pale brown solid precipitated. Remove the solid by vacuum filtration,
After washing with water, drying and recrystallizing with acetone, the melting point was 194.
Tri(methachlorophenyl)bismuth difluoride 2°19 was obtained as a colorless solid at ~197°C. Contains bismuth
136.4% (theoretical value 35°9%).
製造例4 トリ(メタクロルフェニル)(ハイドロオキ
シ)ビスマスクロライド(化合物42)三角フラスコに
製造例2で合成したトリ(メタクロルフェニル)ビスマ
スジクロライド59(0,008モル)およびベンゼン
50xQを入れて溶解した後、28%アンモニア水29
を加えて2〜3分間激しく振った。Production Example 4 Tri(methachlorophenyl)(hydroxy)bismuth chloride (compound 42) Place tri(methachlorophenyl)bismuth dichloride 59 (0,008 mol) synthesized in Production Example 2 and benzene 50xQ in an Erlenmeyer flask and dissolve. After that, add 28% ammonia water 29
was added and shaken vigorously for 2 to 3 minutes.
纏過し、濾液に石油エーテルを加えると、微黄色結品が
析出した。減圧濾過してとり出し乾燥す −ると、融
点(分解)139〜143℃の微黄色固体のトリ(メタ
クロルフェニル)(ハイドロオキシ)ビスマスクロライ
ド3.4gを得た。塩素含量、6.1%(理論値6,0
%)、Bi含爪、34.7%(理論値35.1%)。When the mixture was filtered and petroleum ether was added to the filtrate, a slightly yellow solid precipitated out. It was filtered under reduced pressure, taken out, and dried to obtain 3.4 g of tri(methchlorophenyl)(hydroxy)bismuth chloride as a pale yellow solid with a melting point (decomposition) of 139 to 143°C. Chlorine content, 6.1% (theoretical value 6.0
%), Bi-containing nail, 34.7% (theoretical value 35.1%).
製造例5 トリ(メタクロルフェニル)ビスマスジアセ
テート(化合物49−1)
反応フラスコに製造例2で合成したトリ(メタクロルフ
ェニル)ビスマスジクロライ)’5Li(0,008モ
ル)、ソジウムアセテート2.69(0,032モル)
、アセトン50峠を入れ、室温で4時間反応した後、水
を加えると黄色固体が析出した。Production Example 5 Tri(methachlorophenyl)bismuth diacetate (compound 49-1) In a reaction flask, tri(methachlorophenyl)bismuth dichloride)'5Li (0,008 mol) synthesized in Production Example 2, sodium acetate 2 .69 (0,032 mol)
, acetone 50 was added, and after reacting at room temperature for 4 hours, water was added to precipitate a yellow solid.
減圧濾過して水洗、乾燥した後、アセトンで再結晶する
と、微黄色固体で融点158〜160’Cのトリ(メタ
クロルフェニル)ビスマスジアセテート2.8gを得た
。13i含f1131.0%(理論値31.6%)、塩
素含量0.1%以下。After filtering under reduced pressure, washing with water, drying, and recrystallizing with acetone, 2.8 g of tri(methchlorophenyl)bismuth diacetate was obtained as a pale yellow solid with a melting point of 158 to 160'C. 13i content f1131.0% (theoretical value 31.6%), chlorine content 0.1% or less.
製造例6 トリフェニルビスマスジニトレート(化合物
51)
l)トリフェニルビスマス(化合物l)メタトリフルオ
ロメチルフェニルブロマイドの代りにフェニルクロライ
ド599(0,52モル)を使用して製造例1と同様に
反応し、クロロホルム:メタノールで再結晶することに
より、無色固体のトリフェニルビスマス229を得た。Production Example 6 Triphenylbismuth dinitrate (Compound 51) l) Triphenylbismuth (Compound I) React in the same manner as in Production Example 1 using phenyl chloride 599 (0.52 mol) in place of metatrifluoromethylphenyl bromide. By recrystallizing with chloroform:methanol, colorless solid triphenyl bismuth 229 was obtained.
融点75〜76℃、ガスクロマトグラフィー純度98.
3%、Bi含ff147.1%(理論値47.5%)。Melting point: 75-76°C, gas chromatography purity: 98.
3%, Bi content 147.1% (theoretical value 47.5%).
2)トリフェニルビスマスジクロライド(化合物1G)
トリ(メタクロルフェニル)ビスマスの代りにトリフェ
ニルビスマス16.39(0,037モル)を用いて、
製造例2.2)と同様に反応、処理すると微黄色固体の
トリフェニルビスマスジクロライド13.8yを得た。2) Triphenylbismuth dichloride (compound 1G) Using triphenylbismuth 16.39 (0,037 mol) in place of tri(methachlorophenyl)bismuth,
The reaction and treatment were carried out in the same manner as in Production Example 2.2) to obtain 13.8y of triphenyl bismuth dichloride as a pale yellow solid.
融点132〜136℃、I3i含ff140.5%(理
論値40.9%)、塩素含量!3゜6%(理論値13.
9%)。Melting point: 132-136°C, I3i content: 140.5% (theoretical value: 40.9%), chlorine content! 3°6% (theoretical value 13.
9%).
3)トリフェニルビスマスジニトレート反応フラスコに
上記の如く合成したトリフェニルビスマスジクロライド
59(0,01モル)をアセトン50112に溶かし、
この溶液中に硝酸根3.49(0,02モル)を50%
エタノール水50gに溶解した液を室温で滴下した。減
圧濾過して不溶物をとり出し、乾燥後アセトンで熱時抽
山し放冷すると無色固体のトリフェニルビスマスジニト
レート2.1gが析出した。融点(分解)127〜13
0℃、Bi含ff!37.3 %(理論(a37 、0
%)。3) Triphenyl bismuth dinitrate In a reaction flask, dissolve triphenyl bismuth dichloride 59 (0.01 mol) synthesized as above in acetone 50112,
In this solution, 3.49 (0.02 mol) of nitrate radical was added to 50%
A solution dissolved in 50 g of ethanol water was added dropwise at room temperature. Insoluble materials were removed by filtration under reduced pressure, dried, extracted with acetone while hot, and allowed to cool to precipitate 2.1 g of triphenyl bismuth dinitrate as a colorless solid. Melting point (decomposition) 127-13
0℃, Bi-free! 37.3% (theory (a37, 0
%).
製造例7 ジ(バラクロルフ斗ニル)ビスマスアイオダ
イド(化合物58)
l)トリ(パラクロルフェニル)ビスマス(化合物メタ
トリフルオロメチルフェニルブロマイドの代りにパラク
ロルフェニルブロマイド103.4g(0,54モル)
を使用して製造例1と同様に反応し、ヘキサンで再結晶
することにより、融点104〜106℃の無色固体のト
リ(パラクロルフェニル)ビスマス459を得た。ガス
クロマトグラフィー純[99,6%、Bi含fi38.
8%(理論値38゜4%)。Production Example 7 Di(balachlorphenyl) bismuth iodide (compound 58) l) Tri(parachlorophenyl) bismuth (103.4 g (0.54 mol) of parachlorophenyl bromide instead of the compound metatrifluoromethylphenyl bromide)
The reaction was carried out in the same manner as in Production Example 1 using the following methods, followed by recrystallization with hexane to obtain tri(parachlorophenyl) bismuth 459 as a colorless solid with a melting point of 104 to 106°C. Gas chromatography pure [99.6%, Bi content 38.
8% (theoretical value 38°4%).
2)ジ(パラクロルフェニル)ビスマスアイオダイド
反応フラスコに上記の如く合成したトリ(パラクロルフ
ェニル)ビスマス4y(0,0074モル)、三臭化ビ
スマス1.7f(0,0037モル)、テトラヒドロフ
ラン50JIQを入れ、4時間還流した。2) Di(parachlorophenyl)bismuth iodide In a reaction flask, tri(parachlorophenyl)bismuth 4y (0,0074 mol) synthesized as above, bismuth tribromide 1.7f (0,0037 mol), and tetrahydrofuran 50JIQ was added and refluxed for 4 hours.
冷却して室温でソジウムアイオダイド3.3gのメタノ
ール溶液50xQを加え同温度で6時間反応した。溶媒
を減圧下一部追い出し、水を加えると固体が析出した。After cooling, a methanol solution of 3.3 g of sodium iodide (50xQ) was added at room temperature, and the mixture was reacted at the same temperature for 6 hours. The solvent was partially removed under reduced pressure and water was added to precipitate a solid.
減圧濾過してとり出し、乾燥後、酢酸エチル50村で熱
時抽出して濃縮し、n−ヘキサンで洗浄すると赤色結晶
のジ(パラクロルフェニル)ビスマスアイオダイド4.
39を得た。融点(分解)142〜145℃、Bi含量
37.0%(理論値37.4%)。It is filtered under reduced pressure, dried, extracted with 50 ml of ethyl acetate while hot, concentrated, and washed with n-hexane to give red crystals of di(parachlorophenyl) bismuth iodide.4.
I got 39. Melting point (decomposition) 142-145°C, Bi content 37.0% (theoretical value 37.4%).
?J造例8 ジ(パラフルオロフェニル)ビスマスシ
アナイド(化合物66)
l)トリ(パラフルオロフェニル)ビスマス(化合物1
0)
メタトリフルオロメチルフェニルブロマイドの代りにパ
ラフルオロフェニルブロマイド94.59(0,54モ
ル)を用いて製造例1と同様に反応し、メタノールで再
結晶して、融点92〜93℃、無色固体のトリ(バラフ
ルオロフェニル)ビスマス55.39を得た。ガスクロ
マトグラフィー純度99゜9%、Bi含fj142 、
1 %(理論値42.3 %)。? J Preparation Example 8 Di(parafluorophenyl) bismuth cyanide (Compound 66) l) Tri(parafluorophenyl) bismuth (Compound 1
0) React in the same manner as in Production Example 1 using 94.59 (0.54 mol) of parafluorophenyl bromide instead of metatrifluoromethylphenyl bromide, recrystallize from methanol, and obtain a colorless product with a melting point of 92-93°C. 55.39 g of solid tri(barafluorophenyl)bismuth was obtained. Gas chromatography purity 99.9%, Bi-containing fj142,
1% (theoretical value 42.3%).
、2)ジ(バラフルオロフェニル)ビスマスシアナイド
反応フラスコに、上記の如く合成した斗り(パラフルオ
ロフェニル)ビスマス59(o、o+モル)、三臭化ビ
スマス2.29<0.005モル)、テトラヒドロフラ
ン50xQを入れ4時間還流した。冷却して室温でシア
ン化ナトリウム1.5g(0,03モル)とメタノール
50xQを加え、室温で更に4時間撹拌した。溶媒を一
部追い出し、水を加えると油状物が沈降した。クロロホ
ルムで抽出して濃縮した。lSS縮伸石油エーテルを加
えると白色の固体が析出した。減圧濾過して白色固体を
とり出し、歩出のアセトンに溶解した後、石油エーテル
を加えて再度結晶を析出させて精製した。ジ(パラフル
オロフェニル)ビスマスシアナイドの無色固体2.09
を得た。融点155℃(分解)、Bi含ff149゜6
%(理論値49.2%)。, 2) Di(parafluorophenyl)bismuth cyanide 59 (o, o + mol), bismuth tribromide 2.29 < 0.005 mol) synthesized as above were placed in a di(barafluorophenyl)bismuth cyanide reaction flask. , 50xQ of tetrahydrofuran was added and refluxed for 4 hours. After cooling, 1.5 g (0.03 mol) of sodium cyanide and 50xQ of methanol were added at room temperature, and the mixture was further stirred at room temperature for 4 hours. Some of the solvent was driven off and water was added to precipitate an oil. Extracted with chloroform and concentrated. When lSS condensed petroleum ether was added, a white solid precipitated. A white solid was taken out by filtration under reduced pressure, dissolved in acetone, and purified by adding petroleum ether to precipitate crystals again. Colorless solid of di(parafluorophenyl) bismuth cyanide 2.09
I got it. Melting point: 155°C (decomposition), Bi content: 149°6
% (theoretical value 49.2%).
?aP+9 ジフェニルビスマスアジド(化合物製造
例6.1)で合成したトリフェニルビスマス59(0,
0114モル)、三臭化ビスマス2 、6g(0,00
57モル)およびテトラヒドロフラン50籾を反応フラ
スコに入れて4時間還流した。冷却し、室温でソジウム
アジド2.2g(0,034モル)及びメタノール50
J!12を加え、同温度で更に4時間撹拌した。減圧下
、溶媒を一部追い出した後、水を加えると微黄色固体が
得られた。アセトン二〇−ヘキザン混合溶媒で再結晶す
るとジフェニルビスマスアジドの無色固体1.4gを得
た。融点164°C,Bi含fi51.4%(理論値5
1.6%)。? aP+9 Triphenyl bismuth 59 (0,
0,114 mol), bismuth tribromide 2, 6 g (0,00
57 mol) and tetrahydrofuran and 50 husks of rice were placed in a reaction flask and refluxed for 4 hours. Cool and add 2.2 g (0,034 mol) of sodium azide and 50 g of methanol at room temperature.
J! 12 was added thereto, and the mixture was further stirred at the same temperature for 4 hours. After partially expelling the solvent under reduced pressure, water was added to obtain a pale yellow solid. Recrystallization from a mixed solvent of acetone 20-hexane gave 1.4 g of a colorless solid of diphenyl bismuth azide. Melting point 164°C, Bi content 51.4% (theoretical value 5
1.6%).
製造例10 メタトリルビスマスジ(フェニルザルフ
ァイド)(化合物93)
1)トリ(メタトリル)ビスマス(化合物3)メタトリ
フルオロメチルフェニルブロマイドの代りにメタトリル
ブロマイド92.49(Q、54モル)を使用して製造
例1と同様に反応し、クロロホルム:メタノールで再結
晶することにより、融点48〜49℃の無色の固体、ト
リ(メタトリル)ビスマス54.0gを得た。ガスクロ
マトグラフィー純1i99.9%、Bi含fi43.2
%(理論値43゜3%)。Production Example 10 Methalyl bismuth di(phenyl sulfide) (Compound 93) 1) Tri(methlyl) bismuth (Compound 3) Methalyl bromide 92.49 (Q, 54 mol) was used instead of methatrifluoromethylphenyl bromide The reaction mixture was reacted in the same manner as in Production Example 1, and recrystallized from chloroform:methanol to obtain 54.0 g of tri(methacryl)bismuth, a colorless solid with a melting point of 48 to 49°C. Gas chromatography purity 99.9%, Bi content 43.2
% (theoretical value 43°3%).
2)メタトリルビスマスジ(フェニルサルファイド)
反応フラスコに上記の如く合成したトリ(メタトリル)
ビスマス1.99(0,004モル)、三臭化ビスマス
3.6g(0,008モル)およびジエチルエーテル5
0酎を入れ、室温で1時間撹拌1.た。2) Methatolyl bismuth di(phenyl sulfide) Tri(methatrile) synthesized as above in the reaction flask
Bismuth 1.99 (0,004 mol), bismuth tribromide 3.6 g (0,008 mol) and diethyl ether 5
1. Add 0 shochu and stir at room temperature for 1 hour. Ta.
減圧下、濃縮してジエヂルエーテルを追い出し、アセト
ン5011ρを加えて濾過し、濾液をヂオフェノール2
.69(0,024モル)、トリエチルアミン2.4g
(0,024モル)およびアセトン50肩Qからなる混
合溶液に室温以下で滴下した。滴下後、室温で更に1時
間撹拌し、水を加えて減圧濾過すると黄色の固体が得ら
れた。アセトニトリルで再結晶し、メタトリルビスマス
ジ(フェニルザルファイド)の黄色固体1.5gを得た
。融点127〜131’C(分解)、Bi含fn41
、8 %(理論値40.3%)。Concentrate under reduced pressure to drive off diethyl ether, add acetone 5011ρ, filter, and dilute the filtrate with diophenol 2.
.. 69 (0,024 mol), triethylamine 2.4 g
(0,024 mol) and acetone (0,024 mol) at room temperature or below. After the dropwise addition, the mixture was further stirred at room temperature for 1 hour, water was added, and the mixture was filtered under reduced pressure to obtain a yellow solid. Recrystallization from acetonitrile yielded 1.5 g of a yellow solid of methalyl bismuth di(phenyl sulfide). Melting point 127-131'C (decomposed), Bi-containing fn41
, 8% (theoretical value 40.3%).
製造例11 メタクロルフェニルビスマスビス(ジメヂ
ルジヂオカーバメート)(化合物107)製造例2で合
成したトリ(メタクロルフェニル)ビスマス5.4g(
0,01モル)、三臭化ビスマス9.09(0,02モ
ル)およびジェヂルエーテル70zQを反応フラスコに
入れ、室温で1時間撹拌した。Production Example 11 Metachlorophenyl bismuth bis(dimedyl didiocarbamate) (Compound 107) 5.4 g of tri(methachlorophenyl) bismuth synthesized in Production Example 2 (
0.01 mol), 9.09 (0.02 mol) of bismuth tribromide, and 70zQ of jediyl ether were placed in a reaction flask and stirred at room temperature for 1 hour.
減圧濃縮してジエヂルエーテルを追い出した後、ソジウ
ムジメヂルジチオカーバメート・2水和物11.2g(
0,063モル)およびアセトン100xQを加え、室
温で2時間撹拌した。減圧下、アセトンを一部追い出し
、水を加えて減圧濾過し、黄色固体16.0gを得た。After concentrating under reduced pressure to drive off diethyl ether, 11.2 g of sodium dimedyl dithiocarbamate dihydrate (
0,063 mol) and 100xQ of acetone were added, and the mixture was stirred at room temperature for 2 hours. Part of the acetone was expelled under reduced pressure, water was added, and the mixture was filtered under reduced pressure to obtain 16.0 g of a yellow solid.
アセトニトリルで再結晶すると黄色結晶のメタクロルフ
ェニルビスマスビス(ノメヂルジヂオカーバメー))1
1.8gを得た。When recrystallized with acetonitrile, yellow crystals of methachlorophenyl bismuth bis(nomedyl didiocarbame) 1
1.8g was obtained.
融点〉145℃(分解)、Bi含量39.3%(理論値
38.8%)。Melting point>145°C (decomposition), Bi content 39.3% (theoretical value 38.8%).
製造例12 メタフルオロフェニルビスマスジブロマイ
ド・ジピリジン付加物(化合物110)1)トリ(メタ
フルオロフェニル)ビスマス(化合物9)
メタトリフルオロメチルフェニルブロマイドの代りにメ
タフルオロフェニルブロマイド94.5g(0,54モ
ル)を用いて製造例Iと同様に反応し、メタノールで再
結晶して、融点67〜68′Cの無色の固体トリ(メタ
フルオロフェニル)ビスマス48.59を得た。ガスク
ロマトグラフィー純度98゜0%、Bi含ffk42.
6%(理論値42.3%)。Production Example 12 Metafluorophenyl bismuth dibromide/dipyridine adduct (Compound 110) 1) Tri(metafluorophenyl) bismuth (Compound 9) Metafluorophenyl bromide 94.5 g (0,54 mol) in the same manner as in Preparation Example I and recrystallized from methanol to obtain 48.59 mol of tri(metafluorophenyl) bismuth, a colorless solid having a melting point of 67-68'C. Gas chromatography purity 98.0%, Bi-containing ffk42.
6% (theoretical value 42.3%).
2)メタフルオロフェニルビスマスジブロマイド・ジピ
リジン付加物
反応フラスコに上記の如く合成したトリ(メタフルオロ
フェニル)ビスマス3g(0,006モル)、三臭化ビ
スマス5.4g(0,012モル)およびジエヂルエー
テル50xQを入れ、室温で1時間撹拌した。減圧下、
ジエヂルエーテルを追い出し、ア七トン50xQを加え
て濾過した。濾液を、アセトン50屑Qおよびピリジン
2.8g(0,018モル)の混合液に室温下で滴下し
た。滴下後、濾過し、濾液を一部減圧下濃縮して石油エ
ーテルを加えると微黄色結晶のメタフルオロフェニルビ
スマスジブロマイド・ジピリジン付加物3.59が析出
した。2) Metafluorophenyl bismuth dibromide/dipyridine adduct 3 g (0,006 mol) of tri(metafluorophenyl) bismuth synthesized as above, 5.4 g (0,012 mol) of bismuth tribromide, and diethyl ether were placed in a reaction flask. 50xQ was added thereto, and the mixture was stirred at room temperature for 1 hour. Under reduced pressure
The diethyl ether was expelled, and A7Tone 50xQ was added and filtered. The filtrate was added dropwise to a mixed solution of 50 pieces of acetone and 2.8 g (0,018 mol) of pyridine at room temperature. After the dropwise addition, the mixture was filtered, and the filtrate was partially concentrated under reduced pressure, and petroleum ether was added to precipitate a metafluorophenyl bismuth dibromide/dipyridine adduct (3.59 g) as pale yellow crystals.
融点〉140°C(分解)、Bi含量34.3%(理論
値33.6%)。Melting point>140°C (decomposed), Bi content 34.3% (theoretical value 33.6%).
製造例I3 ジ(メタクロルフェニル)ビスマスブロマ
イド・テトラメヂルアンモニウムクロライド付加物(化
合物75)
Cθ
製造例2.1)で得たトリ(メタクロルフェニル)ビス
マス4g(0,007モル)、三臭化ビスマス!。Production Example I3 Di(methachlorophenyl)bismuth bromide/tetramedylammonium chloride adduct (compound 75) Cθ 4 g (0,007 mol) of tri(methachlorophenyl)bismuth obtained in Production Example 2.1), tri-odor Bismuth! .
7g(0,0037モル)およびテトラヒドロフラン5
0mgを反応フラスコに入れ、4時間加熱還流した。減
圧下、濃縮してテトラヒドロフランを追い出し、メタノ
ール50x(2を加えて濾過した。濾液をテトラメチル
アンモニウムクロライド1.29(o、o t tモル
)とメタノール50村との混合液に、室温下、加えた。7 g (0,0037 mol) and tetrahydrofuran 5
0 mg was placed in a reaction flask and heated under reflux for 4 hours. Concentrate under reduced pressure to drive off tetrahydrofuran, add 50x methanol and filter.The filtrate was added to a mixture of 1.29 (o, ot t mol) of tetramethylammonium chloride and 50 ml of methanol at room temperature. added.
20分間加熱還流した後、減圧下、メタノールを追い出
し、アセトン50112に溶解してn−ヘキサノを加え
、無色の結晶としてジ(メタクロルフェニル)ビスマス
ブロマイド・テトラメヂルアンモニウムクロライド付加
物2.6gを得た。融点155℃(分解)、BrCQ、
含219.0%(理論値18.6%)、Bi含fn33
.6%(理論値33゜6%)。After heating under reflux for 20 minutes, methanol was expelled under reduced pressure, dissolved in acetone 50112, and n-hexano was added to give 2.6 g of di(methchlorophenyl) bismuth bromide tetramedylammonium chloride adduct as colorless crystals. Obtained. Melting point 155°C (decomposition), BrCQ,
Contains 219.0% (theoretical value 18.6%), Bi-contains fn33
.. 6% (theoretical value 33°6%).
上記の製造例と同様にして本発明に係る他の化合物を合
成した。以下の表1にそれらの化合物を示す。Other compounds according to the present invention were synthesized in the same manner as in the above production examples. Table 1 below shows those compounds.
人−上 2) !=3、t=2 4) s=3、t=2 5) s−2、t=1 6) !1=2− t=1 8)s=I、L=1 注: 上記の表中、φはフェニル基を表わす。person-upper 2)! =3, t=2 4) s=3, t=2 5) s-2, t=1 6)! 1=2- t=1 8) s=I, L=1 Note: In the above table, φ represents a phenyl group.
以下に実施例を挙げ、上記の化合物を主成分と−する本
発明製剤の調製方法を説明する。Examples are given below to explain the preparation method of the preparation of the present invention containing the above-mentioned compound as a main component.
実施例1
本発明化合物10重量%を乳糖90重量%とよく混和し
、10倍散とする。投与時には、これを飼料で0.O1
〜0.05%の有効物質濃度に希釈して使用する。Example 1 10% by weight of the compound of the present invention is thoroughly mixed with 90% by weight of lactose to form a 10-fold powder. At the time of administration, 0.0% of this was administered as feed. O1
Use diluted to an active substance concentration of ~0.05%.
実施例2
本発明化合物10重量%を澱粉90重量%とよく混和し
、10倍散とする。投与時には、これを飼料で0.O1
〜0.05%の有効物質濃度に希釈して使用する。Example 2 10% by weight of the compound of the present invention is thoroughly mixed with 90% by weight of starch to form a 10-fold powder. At the time of administration, 0.0% of this was administered as feed. O1
Use diluted to an active substance concentration of ~0.05%.
実施例3
本発明化合物25重量部と小麦粉75重量部と均一に混
和して粉剤とする。投与時には、これを飼料で0.O1
〜0.05%の有効物質濃度に希釈して使用する。Example 3 25 parts by weight of the compound of the present invention and 75 parts by weight of wheat flour are uniformly mixed to form a powder. At the time of administration, 0.0% of this was administered as feed. O1
Use diluted to an active substance concentration of ~0.05%.
効果
本発明製剤は投与対象である家禽類に対する毒性が低く
、しかし、家禽類のコクシジウム症の予防および治療上
有効である。Effects The preparation of the present invention has low toxicity to poultry to which it is administered, but is effective in preventing and treating coccidiosis in poultry.
以下の表2に、毒性試験の結果の一部を示す。Table 2 below shows some of the results of the toxicity tests.
本発明製剤のインビボにおける抗コクシジウム作用を以
下の試験例に示す如くにして調べた。The in vivo anticoccidial effect of the formulation of the present invention was investigated as shown in the following test example.
試験例
1)試験方法
7〜10令の白色レグポンのヒナ5羽を1群とし、これ
にアイメリア・テネラの胞子形成オーシストを1羽あた
り、50,000個感染させた。Test Example 1) Test Method A group of five white Regpon chicks aged 7 to 10 were infected with 50,000 spore-forming oocysts of Eimeria tenella per bird.
感染前日から飼料に検体を添加して9日間連続投与し、
感染8日目に剖検し、盲腸病変を観察し、その間の血便
の排泄程度、生存率、相対増体重および盲腸病変値を算
出した。The sample was added to the feed from the day before infection and administered continuously for 9 days.
Necropsy was performed on the 8th day after infection, cecal lesions were observed, and the extent of bloody stool excretion, survival rate, relative weight gain, and cecal lesion values were calculated.
2)試験成績
ニワトリヒナのコクシジウム症(アイメリア・テネラ)
に対するインビボ試験の成績を表3に示す。2) Test results Coccidiosis in chicken chicks (Eimeria tenella)
Table 3 shows the results of in-vivo tests for.
表中、下記の語句は次の意味を有する。In the table, the following words have the following meanings:
相対増体重:試験群の体重増加量を、無感染対照群の体
重増加量に対する比
率で表わす。Relative weight gain: The weight gain of the test group is expressed as a ratio to the weight gain of the uninfected control group.
血便の排泄;5羽当りの試験期間中に排泄される血便排
泄の程度を−〜++
+の4段階で評価した結果を示
す。Excretion of bloody stool: The results of evaluating the degree of bloody stool excreted per 5 birds during the test period on a 4-grade scale from - to +++ are shown.
一:血便排泄が認められない。1: No bloody stool excretion is observed.
+:軽度の血便排泄 ++:中度の血便排泄 +++:感染無投薬対照群と同程 度の血便排泄 盲腸病変値:メルクの検定法による。+: Mild bloody stool excretion ++: Moderate bloody stool excretion +++: Same as the infection-free control group Frequent hematochezia Cecal lesion value: Based on Merck's test method.
生存したヒナを感染8日後に剖 検し、盲腸病変を肉眼的に観察 し、その病変程度をO〜4に分 けて(重度のものを4とし、病 変なしのものを0とし)その間 の強度を判定し、5羽分を合計 した平均値で表わす。Surviving chicks were sacrificed 8 days after infection. and visually observe the cecal lesions. The degree of the lesion was divided into 0 to 4. (severe is rated 4, disease is (If there is no change, it is set as 0) Determine the strength of It is expressed as the average value.
13 ニワトリヒナのコクシジウム症(アイメリア・
テネラ)に対する予防効果13 Coccidiosis in chicken chicks (Eimeria
Preventive effect against (Tenella)
Claims (1)
はトリフルオロメチル、sは1〜3の整数、tは0〜2
の整数であって、sが1のときtは1または2であり、
tが1のときQは−Br_2(ピリジン)_2または−
Br_2(ジピリジル)、tが2のときQはフェニルチ
オ、N、N−ジメチルアミノチオカルボニルチオを表わ
し、sが2のときtは1であって、Qは沃素、シアノ、
アジド、−Br(フェニルトリメチルアンモニウム・ハ
ライド)、−Br(テトラメチルアンモニウム・ハライ
ド)、または−Br(テトラエチルアンモニウム・ハラ
イド)を表わし、sが3のときtは0、1または2であ
って、tが1のときQは−Cl(OH)、tが2のとき
Qは弗素、塩素、アセトキシまたは硝酸根を表わす] で示される有機ビスマス化合物を有効成分とする家禽用
抗コクシジウム剤。 2、一般式( I )で示される化合物を0.01重量%
〜0.08重量%の割合で含有する第1項記載の家禽用
抗コクシジウム剤。[Claims] 1. General formula (I): ▲Mathematical formulas, chemical formulas, tables, etc.▼(I) [In the formula, A is hydrogen, fluorine, chlorine, methyl, methoxy or trifluoromethyl, and s is 1 An integer of ~3, t is 0 to 2
is an integer of , and when s is 1, t is 1 or 2,
When t is 1, Q is -Br_2 (pyridine)_2 or -
Br_2 (dipyridyl), when t is 2, Q represents phenylthio, N,N-dimethylaminothiocarbonylthio, when s is 2, t is 1, and Q is iodine, cyano,
represents azide, -Br (phenyltrimethylammonium halide), -Br (tetramethylammonium halide), or -Br (tetraethylammonium halide), and when s is 3, t is 0, 1 or 2, When t is 1, Q represents -Cl(OH), and when t is 2, Q represents fluorine, chlorine, acetoxy or nitrate. 2. 0.01% by weight of the compound represented by general formula (I)
The poultry anticoccidial agent according to item 1, containing the poultry anticoccidial agent in a proportion of ~0.08% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP392087A JPS63174926A (en) | 1987-01-09 | 1987-01-09 | Anticoccidial agent for domestic fowl |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP392087A JPS63174926A (en) | 1987-01-09 | 1987-01-09 | Anticoccidial agent for domestic fowl |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63174926A true JPS63174926A (en) | 1988-07-19 |
Family
ID=11570587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP392087A Pending JPS63174926A (en) | 1987-01-09 | 1987-01-09 | Anticoccidial agent for domestic fowl |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63174926A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702729A (en) * | 1995-12-07 | 1997-12-30 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria |
US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US5827543A (en) * | 1995-12-07 | 1998-10-27 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of urogenital disorders |
US5882686A (en) * | 1995-12-07 | 1999-03-16 | The Procter & Gamble Company | Methods for the prevention and treatment of urogenital disorders |
US5932564A (en) * | 1995-12-07 | 1999-08-03 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders |
US6051604A (en) * | 1995-12-07 | 2000-04-18 | The Proctor & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
WO2004067505A3 (en) * | 2003-01-29 | 2005-05-06 | Univ Singapore | Bismuth dithiocarbamate compounds and uses thereof |
WO2008108500A1 (en) * | 2007-03-07 | 2008-09-12 | Otsuka Chemical Co., Ltd. | Living radical polymerization promoter |
WO2021261571A1 (en) * | 2020-06-24 | 2021-12-30 | 国立大学法人北海道大学 | Blood-cerebrospinal fluid barrier protecting agent |
-
1987
- 1987-01-09 JP JP392087A patent/JPS63174926A/en active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702729A (en) * | 1995-12-07 | 1997-12-30 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria |
US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US5827543A (en) * | 1995-12-07 | 1998-10-27 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of urogenital disorders |
US5882686A (en) * | 1995-12-07 | 1999-03-16 | The Procter & Gamble Company | Methods for the prevention and treatment of urogenital disorders |
US5932564A (en) * | 1995-12-07 | 1999-08-03 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders |
US6051604A (en) * | 1995-12-07 | 2000-04-18 | The Proctor & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
WO2004067505A3 (en) * | 2003-01-29 | 2005-05-06 | Univ Singapore | Bismuth dithiocarbamate compounds and uses thereof |
WO2008108500A1 (en) * | 2007-03-07 | 2008-09-12 | Otsuka Chemical Co., Ltd. | Living radical polymerization promoter |
US8076430B2 (en) | 2007-03-07 | 2011-12-13 | Otsuka Chemical Co., Ltd. | Living radical polymerization promoter |
JP5380709B2 (en) * | 2007-03-07 | 2014-01-08 | 大塚化学株式会社 | Living radical polymerization reaction promoter |
WO2021261571A1 (en) * | 2020-06-24 | 2021-12-30 | 国立大学法人北海道大学 | Blood-cerebrospinal fluid barrier protecting agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6596537B2 (en) | 2,3-Dihydro-isoindol-1-one derivatives as BTK kinase inhibitors and pharmaceutical compositions containing the same | |
TWI530501B (en) | Process for purifying staurosporine | |
CN1117044A (en) | Substituted N-heteroaroaroylguanidin, preparation, pharmaceutical application and medicine containg same | |
KR100442096B1 (en) | Antitumor derivative of double dicarboxylic acid diaminoplatin complex, process for the preparing thereof, the pharmaceutical composition containing the same and application of the derivative | |
EP0124476B1 (en) | Carboxamides, process for their preparation and pharmaceutical preparations containing them | |
CN108440345B (en) | Preparation method of sulfonamide compound | |
EP3448375B1 (en) | Benzoylglycine derivatives and methods of making and using same | |
JPS63174926A (en) | Anticoccidial agent for domestic fowl | |
NO318648B1 (en) | Use of 6-substituted acylfulven analogs having anti-tumor effect | |
JP2019505548A (en) | MAX binders and their use as MYC modulators | |
EP0202673B1 (en) | Titanocene complexes having a cytostatic activity | |
EA014909B1 (en) | Crystalline forms of gemcitabine amide prodrug, compositions based thereon and use thereof | |
JPH0432051B2 (en) | ||
US3298917A (en) | Antidiabetic nu-acylaliphaticsulfonamides | |
CN114853748A (en) | Trifluoromethyl-containing isoxazoline derivative, and preparation method and application thereof | |
CN111377913A (en) | 9-alkoxy berberine salt, synthesis method and application | |
CN106565744A (en) | Crystal form of PA-824 compound and preparation method of crystal form | |
RU2816109C1 (en) | Fluorine-containing triarylantimony (v) dicarboxylates, having antileishmanial activity | |
CN112480104B (en) | Nitrazonit derivative and medical application thereof | |
JPS6252757B2 (en) | ||
WO2023241507A1 (en) | Crystal form of alkynylpyridine compound and preparation method therefor | |
CN116715715A (en) | Novel alkaloid derivative and synthesis method and application thereof | |
US20220204538A1 (en) | Anti-cancer gold compounds | |
EP0125695B1 (en) | 2-bromo-1-tetralone derivatives | |
RU2186057C1 (en) | 4-nitro-3-fluoromethylperfluorononanoylanilide (flustat), method if its synthesis and pharmaceutical composition based on thereof |